Document is current
Any future updates will be listed below
-
Authors
Panariello, Francesco https://orcid.org/0000-0002-0351-5689
Gagliano, Onelia https://orcid.org/0000-0002-2571-3176
Luni, Camilla https://orcid.org/0000-0002-1211-9629
Grimaldi, Antonio
Angiolillo, Silvia
Qin, Wei
Manfredi, Anna
Annunziata, Patrizia
Slovin, Shaked
Vaccaro, Lorenzo
Riccardo, Sara
Bouche, Valentina
Dionisi, Manuela
Salvi, Marcello
Martewicz, Sebastian https://orcid.org/0000-0001-6663-301X
Hu, Manli
Cui, Meihua
Stuart, Hannah
Laterza, Cecilia https://orcid.org/0000-0002-3964-3375
Baruzzo, Giacomo https://orcid.org/0000-0001-6129-5007
Schiebinger, Geoffrey https://orcid.org/0000-0002-8290-7997
Di Camillo, Barbara https://orcid.org/0000-0001-8415-4688
Cacchiarelli, Davide https://orcid.org/0000-0002-9621-6716
Elvassore, Nicola https://orcid.org/0000-0002-7029-6287
- License Information
-
More Information
Article History
Received: 31 October 2022
Accepted: 9 March 2023
First Online: 17 May 2023
Competing interests
: O.G, Ca.L. and N.E. are co-inventors on patent applications describing the reprogramming and differentiation processes in microfluidics, application number PD2013A000220, IT UA20162645 and 102016000039189 and PCT/IB2017/052167. O.G. and N.E. are co-founders of Onyel Biotech Srl. D.C. is founder, shareholder, and consultant of Next Generation Diagnostic srl. The remaining authors declare no competing interests.
